Frontiers in Oncology

Original Research

Published on 29 Nov 2022

Tuning the optimal diffusion-weighted MRI parameters on a 0.35-T MR-Linac for clinical implementation: A phantom study

in Radiation Oncology

Matteo Nardini
Amedeo Capotosti
Lorenzo Nicola Mazzoni
Davide Cusumano
Luca Boldrini
Giuditta Chiloiro
Angela Romano
Vincenzo Valentini
Luca Indovina
Lorenzo Placidi

Frontiers in Oncology

doi 10.3389/fonc.2022.867792

3,102 views
9 citations

Systematic Review

Published on 29 Nov 2022

Nutrition management for patients with head and neck cancer during peri-radiotherapy: A systematic review and quality appraisal of clinical practice guidelines using the AGREE II instrument

in Cancer Metabolism

Jing Zhao
Yajing Kan
Xueting Wu
Shuang Yang
Guozhou Wang
Yuting Bao
Jing Li

Frontiers in Oncology

doi 10.3389/fonc.2022.974059

4,711 views
2 citations

Original Research

Published on 29 Nov 2022

High expression of RARG accelerates ovarian cancer progression by regulating cell proliferation

in Gynecological Oncology

Lin Xiu
Yuxi Zhao
Ning Li
Jia Zeng
Jing Liu
Yongliang Fu
Qiao Gao
Lingying Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.1063031

3,432 views
10 citations

Original Research

Published on 29 Nov 2022

Coping strategies and considerations regarding low anterior resection syndrome and quality of life among patients with rectal cancer; a qualitative interview study

in Gastrointestinal Cancers: Colorectal Cancer

Birgitte Schantz Laursen
Gitte Kjær Sørensen
Margit Majgaard
Line Byskov Jensen
Karen Irene Jacobsen
Dorte Kløve Kjær
Therese Juul
Peter Christensen
Anette Højer Mikkelsen

Frontiers in Oncology

doi 10.3389/fonc.2022.1040462

3,791 views
8 citations

Brief Research Report

Published on 29 Nov 2022

Combining superselective catheterization and electrochemotherapy: A new technological approach to the treatment of high-flow head and neck vascular malformations

in Cancer Molecular Targets and Therapeutics

Aljosa Krt
Maja Cemazar
Dimitrij Lovric
Gregor Sersa
Crt Jamsek
Ales Groselj

Frontiers in Oncology

doi 10.3389/fonc.2022.1025270

3,263 views
11 citations

Original Research

Published on 29 Nov 2022

Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity

in Cancer Molecular Targets and Therapeutics

Artem Gridnev
Subhajit Maity
Jyoti R. Misra

Frontiers in Oncology

doi 10.3389/fonc.2022.1021823

6,490 views
17 citations

Original Research

Published on 29 Nov 2022

PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression

in Cancer Genetics

Jianzhong Peng
Tao Wang
Chao Yue
Xianyan Luo
Peng Xiao

Frontiers in Oncology

doi 10.3389/fonc.2022.1004511

2,717 views
10 citations

Original Research

Published on 29 Nov 2022

3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction

in Molecular and Cellular Oncology

Huan Zhang
Huanyao Gao
Yayun Gu
August John
Lixuan Wei
Minhong Huang
Jia Yu
Adeyemi A. Adeosun
Richard M. Weinshilboum
Liewei Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.999302

5,039 views
9 citations

Original Research

Published on 29 Nov 2022

Unsuccessful external validation of the MAC-score for predicting increased MIB-1 index in patients with spinal meningiomas

in Neuro-Oncology and Neurosurgical Oncology

Victor Gabriel El-Hajj
Alexander Fletcher-Sandersjöö
Jenny Pettersson-Segerlind
Erik Edström
Adrian Elmi-Terander

Frontiers in Oncology

doi 10.3389/fonc.2022.1037495

1,360 views
6 citations

Original Research

Published on 29 Nov 2022

Added survival benefit of whole brain radiotherapy in brain metastatic non-small cell lung cancer: Development and external validation of an individual prediction model

in Radiation Oncology

Kyrhatii Trikhirhisthit
Jiraporn Setakornnukul
Kullathorn Thephamongkhol

Frontiers in Oncology

doi 10.3389/fonc.2022.911835

3,343 views
6 citations

Mini Review

Published on 29 Nov 2022

Management of infantile hemangiomas: Recent advances

in Pediatric Oncology

Wei Xu
Haiguang Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.1064048

7,289 views
15 citations

Original Research

Published on 29 Nov 2022

Efficacy and feasibility of snare-assisted endoscopic resection of small submucosal gastric tumors: A retrospective analysis

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Fei Zhao
Zhenzhen Liu
Anwei Wei
Wei Wang
Na Xu
Xuanmei Pu
Saif Ullah

Frontiers in Oncology

doi 10.3389/fonc.2022.1068183

1,699 views
1 citation

Original Research

Published on 29 Nov 2022

Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer

in Gastrointestinal Cancers: Colorectal Cancer

Daniele Lavacchi
Sara Fancelli
Giandomenico Roviello
Francesca Castiglione
Enrico Caliman
Gemma Rossi
Jacopo Venturini
Elisa Pellegrini
Marco Brugia
Agnese Vannini

Frontiers in Oncology

doi 10.3389/fonc.2022.1055019

5,479 views
15 citations

Original Research

Published on 29 Nov 2022

Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis

in Thoracic Oncology

Lupeng Qiu
Shan Gao
Sicheng Du
Shengjie Sun
Yanjie Liang
Zhuoya Sun
Tao Li
Guhe Jia
Ke Li
Xiaohui Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.974227

2,455 views
3 citations

Original Research

Published on 29 Nov 2022

Single-cell analyses reveal the therapeutic effects of ATHENA and its mechanism in a rhabdomyosarcoma patient

in Cancer Immunity and Immunotherapy

Yujun Liu
Ke Wang
Yanli Zhou
Xibing Zhuang
Shali Shao
Fulu Qiao
Xiangdong Wang
Xin Zou
Tiankui Qiao

Frontiers in Oncology

doi 10.3389/fonc.2022.1039145

4,101 views
2 citations

Original Research

Published on 29 Nov 2022

Pathological complete remission in ALK-positive lung cancer patient after multiple lines of conversion therapy

in Cancer Molecular Targets and Therapeutics

Dan Que
Hongbo Zou
Bijing Mao
Huan Zhang
Wei Liang
Qin Liu
Leiyu Ke
Lijie Guo
Qichao Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.967675

4,955 views
2 citations